Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin Infusion for HCC Patients After Hepatectomy
NCT03974074Phase 3Unknown
- Sponsor
- Guangxi Medical University
- Start
- Mar 2019
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of albumin (human) in hypoproteinemia, sponsored by Guangxi Medical University. Status: unknown.
02
Drugs
albumin (human)
03
Conditions
hypoproteinemia
Beyond the preview
Go deeper on NCT03974074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03974074.